Logo image of DLB

DOLBY LABORATORIES INC-CL A (DLB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:DLB - US25659T1079 - Common Stock

67.45 USD
+0.45 (+0.67%)
Last: 11/28/2025, 8:24:14 PM
67.45 USD
0 (0%)
After Hours: 11/28/2025, 8:24:14 PM
Fundamental Rating

7

Taking everything into account, DLB scores 7 out of 10 in our fundamental rating. DLB was compared to 280 industry peers in the Software industry. DLB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DLB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

DLB had positive earnings in the past year.
DLB had a positive operating cash flow in the past year.
Each year in the past 5 years DLB has been profitable.
In the past 5 years DLB always reported a positive cash flow from operatings.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 7.90%, DLB is doing good in the industry, outperforming 79.72% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.72%, DLB is in the better half of the industry, outperforming 75.09% of the companies in the same industry.
DLB has a better Return On Invested Capital (8.48%) than 80.07% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DLB is below the industry average of 12.00%.
Industry RankSector Rank
ROA 7.9%
ROE 9.72%
ROIC 8.48%
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

The Profit Margin of DLB (18.90%) is better than 82.92% of its industry peers.
DLB's Profit Margin has been stable in the last couple of years.
DLB's Operating Margin of 20.75% is amongst the best of the industry. DLB outperforms 86.48% of its industry peers.
In the last couple of years the Operating Margin of DLB has grown nicely.
With an excellent Gross Margin value of 88.13%, DLB belongs to the best of the industry, outperforming 95.02% of the companies in the same industry.
In the last couple of years the Gross Margin of DLB has remained more or less at the same level.
Industry RankSector Rank
OM 20.75%
PM (TTM) 18.9%
GM 88.13%
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLB is destroying value.
The number of shares outstanding for DLB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DLB has less shares outstanding
There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 8.59 indicates that DLB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.59, DLB belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.59
ROIC/WACC0.77
WACC11%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 3.17 indicates that DLB has no problem at all paying its short term obligations.
DLB's Current ratio of 3.17 is fine compared to the rest of the industry. DLB outperforms 77.22% of its industry peers.
DLB has a Quick Ratio of 3.10. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
DLB has a better Quick ratio (3.10) than 77.58% of its industry peers.
Industry RankSector Rank
Current Ratio 3.17
Quick Ratio 3.1
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.84% over the past year.
The Earnings Per Share has been growing by 8.55% on average over the past years. This is quite good.
DLB shows a small growth in Revenue. In the last year, the Revenue has grown by 5.92%.
The Revenue has been growing slightly by 3.03% on average over the past years.
EPS 1Y (TTM)11.84%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%22.22%
Revenue 1Y (TTM)5.92%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%0.73%

3.2 Future

The Earnings Per Share is expected to grow by 5.99% on average over the next years.
DLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y0.45%
EPS Next 2Y4.56%
EPS Next 3Y5.99%
EPS Next 5YN/A
Revenue Next Year4.41%
Revenue Next 2Y4.46%
Revenue Next 3Y4.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.87 indicates a correct valuation of DLB.
DLB's Price/Earnings ratio is rather cheap when compared to the industry. DLB is cheaper than 80.43% of the companies in the same industry.
When comparing the Price/Earnings ratio of DLB to the average of the S&P500 Index (26.31), we can say DLB is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.80, which indicates a correct valuation of DLB.
DLB's Price/Forward Earnings ratio is rather cheap when compared to the industry. DLB is cheaper than 80.07% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. DLB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.87
Fwd PE 15.8
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

DLB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DLB is cheaper than 82.21% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DLB is valued cheaply inside the industry as 85.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.97
EV/EBITDA 15.6
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DLB does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of DLB may justify a higher PE ratio.
PEG (NY)35.62
PEG (5Y)1.86
EPS Next 2Y4.56%
EPS Next 3Y5.99%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.15%, DLB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 50.16, DLB pays a better dividend. On top of this DLB pays more dividend than 95.37% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, DLB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

On average, the dividend of DLB grows each year by 8.45%, which is quite nice.
DLB has paid a dividend for at least 10 years, which is a reliable track record.
DLB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.45%
Div Incr Years10
Div Non Decr Years10
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

49.64% of the earnings are spent on dividend by DLB. This is a bit on the high side, but may be sustainable.
The dividend of DLB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP49.64%
EPS Next 2Y4.56%
EPS Next 3Y5.99%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DOLBY LABORATORIES INC-CL A

NYSE:DLB (11/28/2025, 8:24:14 PM)

After market: 67.45 0 (0%)

67.45

+0.45 (+0.67%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-18 2025-11-18/amc
Earnings (Next)01-27 2026-01-27
Inst Owners98.07%
Inst Owner Change0.04%
Ins Owners1.08%
Ins Owner Change-1.62%
Market Cap6.44B
Revenue(TTM)1.35B
Net Income(TTM)255.02M
Analysts78
Price Target97.67 (44.8%)
Short Float %4.31%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend1.33
Dividend Growth(5Y)8.45%
DP49.64%
Div Incr Years10
Div Non Decr Years10
Ex-Date12-02 2025-12-02 (0.36)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.15%
Min EPS beat(2)8.26%
Max EPS beat(2)40.03%
EPS beat(4)4
Avg EPS beat(4)15.05%
Min EPS beat(4)4.74%
Max EPS beat(4)40.03%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)11
Avg EPS beat(12)17.11%
EPS beat(16)13
Avg EPS beat(16)13.44%
Revenue beat(2)1
Avg Revenue beat(2)1.06%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)2.35%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)2.35%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)5
Avg Revenue beat(12)0.94%
Revenue beat(16)5
Avg Revenue beat(16)-0.33%
PT rev (1m)0%
PT rev (3m)-7.04%
EPS NQ rev (1m)-22.87%
EPS NQ rev (3m)-22.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-9.51%
Revenue NQ rev (3m)-9.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE 15.87
Fwd PE 15.8
P/S 4.78
P/FCF 14.97
P/OCF 13.64
P/B 2.46
P/tB 3.8
EV/EBITDA 15.6
EPS(TTM)4.25
EY6.3%
EPS(NY)4.27
Fwd EY6.33%
FCF(TTM)4.5
FCFY6.68%
OCF(TTM)4.94
OCFY7.33%
SpS14.13
BVpS27.46
TBVpS17.75
PEG (NY)35.62
PEG (5Y)1.86
Graham Number51.24
Profitability
Industry RankSector Rank
ROA 7.9%
ROE 9.72%
ROCE 10.03%
ROIC 8.48%
ROICexc 11.34%
ROICexgc 20.4%
OM 20.75%
PM (TTM) 18.9%
GM 88.13%
FCFM 31.89%
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
ROICexc(3y)11.58%
ROICexc(5y)13.02%
ROICexgc(3y)19.56%
ROICexgc(5y)20.42%
ROCE(3y)10.05%
ROCE(5y)10.27%
ROICexgc growth 3Y7.72%
ROICexgc growth 5Y2.66%
ROICexc growth 3Y-0.34%
ROICexc growth 5Y-1.41%
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 47.75%
Cap/Sales 3.11%
Interest Coverage 250
Cash Conversion 128.39%
Profit Quality 168.72%
Current Ratio 3.17
Quick Ratio 3.1
Altman-Z 8.59
F-Score7
WACC11%
ROIC/WACC0.77
Cap/Depr(3y)41.38%
Cap/Depr(5y)49.64%
Cap/Sales(3y)2.6%
Cap/Sales(5y)3.36%
Profit Quality(3y)150.02%
Profit Quality(5y)143.52%
High Growth Momentum
Growth
EPS 1Y (TTM)11.84%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%22.22%
EPS Next Y0.45%
EPS Next 2Y4.56%
EPS Next 3Y5.99%
EPS Next 5YN/A
Revenue 1Y (TTM)5.92%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%0.73%
Revenue Next Year4.41%
Revenue Next 2Y4.46%
Revenue Next 3Y4.88%
Revenue Next 5YN/A
EBIT growth 1Y5.76%
EBIT growth 3Y8.83%
EBIT growth 5Y4.89%
EBIT Next Year20.63%
EBIT Next 3Y11.28%
EBIT Next 5YN/A
FCF growth 1Y44.75%
FCF growth 3Y18.42%
FCF growth 5Y9.38%
OCF growth 1Y44.29%
OCF growth 3Y14.01%
OCF growth 5Y6.55%

DOLBY LABORATORIES INC-CL A / DLB FAQ

What is the fundamental rating for DLB stock?

ChartMill assigns a fundamental rating of 7 / 10 to DLB.


Can you provide the valuation status for DOLBY LABORATORIES INC-CL A?

ChartMill assigns a valuation rating of 6 / 10 to DOLBY LABORATORIES INC-CL A (DLB). This can be considered as Fairly Valued.


What is the profitability of DLB stock?

DOLBY LABORATORIES INC-CL A (DLB) has a profitability rating of 7 / 10.


What is the valuation of DOLBY LABORATORIES INC-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DOLBY LABORATORIES INC-CL A (DLB) is 15.87 and the Price/Book (PB) ratio is 2.46.


Is the dividend of DOLBY LABORATORIES INC-CL A sustainable?

The dividend rating of DOLBY LABORATORIES INC-CL A (DLB) is 6 / 10 and the dividend payout ratio is 49.64%.